Skip to main content

Published locations for Checkmate 238: Nivolumab bests ipilimumab for resectable stage III or IV melanoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Checkmate 238: Nivolumab bests ipilimumab for resectable stage III or IV melanoma

User login

  • Reset your password
  • /content/checkmate-238-nivolumab-bests-ipilimumab-resectable-stage-iii-or-iv-melanoma
  • /edermatologynews/article/146777/immuno-oncology/checkmate-238-nivolumab-bests-ipilimumab-resectable
  • /oncologypractice/article/146777/immuno-oncology/checkmate-238-nivolumab-bests-ipilimumab-resectable
  • /hematology-oncology/article/146777/immuno-oncology/checkmate-238-nivolumab-bests-ipilimumab
  • /dermatology/article/146777/immuno-oncology/checkmate-238-nivolumab-bests-ipilimumab-resectable-stage